SELPLG and acute myeloid leukemia: Indeed, only 2.2 ± 1.6% of Selplg–/– AML blasts were quiescent in vivo, compared to 33.3 ± 7.4% in WT AML (p < 0.0001) (Figure 4D, top panel).